Report Detail
Global Biopharmaceuticals Market Insights, Forecast to 2025
- RnM2931038 |
- 12 February, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated
With manufacturing (if the trials are successful).
An additional point is that European R&D costs are higher than in other world regions due to the fragmented European patent system. The implications of a fragmented patent system in Europe include high uncertainty, quality drop and prohibitive costs, which are at least four times higher than in the US, China and South Korea thus constituting a financial burden on especially small biopharmaceutical enterprises in Europe (van Pottelsberghe 2009).
The global Biopharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biopharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of Biopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biopharmaceuticals in these regions.
This research report categorizes the global Biopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Biopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Market size by Product
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Market size by End User
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Biopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biopharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Biopharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Biopharmaceuticals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Biopharmaceuticals Market Size Growth Rate by Product
- 1.4.2 Monoclonal Antibodies
- 1.4.3 Interferon
- 1.4.4 Colony-Stimulating Factor
- 1.4.5 Erythropoietin
- 1.4.6 Insulin
- 1.4.7 Vaccines
- 1.4.8 Growth Hormones
- 1.4.9 Others
- 1.5 Market by End User
- 1.5.1 Global Biopharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Tumor
- 1.5.3 Diabetes
- 1.5.4 Cardiovascular
- 1.5.5 Hemophilia
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biopharmaceuticals Market Size
- 2.1.1 Global Biopharmaceuticals Revenue 2014-2025
- 2.1.2 Global Biopharmaceuticals Sales 2014-2025
- 2.2 Biopharmaceuticals Growth Rate by Regions
- 2.2.1 Global Biopharmaceuticals Sales by Regions
- 2.2.2 Global Biopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Biopharmaceuticals Sales by Manufacturers
- 3.1.1 Biopharmaceuticals Sales by Manufacturers
- 3.1.2 Biopharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.2 Biopharmaceuticals Revenue by Manufacturers
- 3.2.1 Biopharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Biopharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.3 Biopharmaceuticals Price by Manufacturers
- 3.4 Biopharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Biopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biopharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Biopharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Biopharmaceuticals Sales by Product
- 4.2 Global Biopharmaceuticals Revenue by Product
- 4.3 Biopharmaceuticals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Biopharmaceuticals Breakdown Data by End User
6 North America
- 6.1 North America Biopharmaceuticals by Countries
- 6.1.1 North America Biopharmaceuticals Sales by Countries
- 6.1.2 North America Biopharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Biopharmaceuticals by Product
- 6.3 North America Biopharmaceuticals by End User
7 Europe
- 7.1 Europe Biopharmaceuticals by Countries
- 7.1.1 Europe Biopharmaceuticals Sales by Countries
- 7.1.2 Europe Biopharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biopharmaceuticals by Product
- 7.3 Europe Biopharmaceuticals by End User
8 Asia Pacific
- 8.1 Asia Pacific Biopharmaceuticals by Countries
- 8.1.1 Asia Pacific Biopharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific Biopharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Biopharmaceuticals by Product
- 8.3 Asia Pacific Biopharmaceuticals by End User
9 Central & South America
- 9.1 Central & South America Biopharmaceuticals by Countries
- 9.1.1 Central & South America Biopharmaceuticals Sales by Countries
- 9.1.2 Central & South America Biopharmaceuticals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Biopharmaceuticals by Product
- 9.3 Central & South America Biopharmaceuticals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Biopharmaceuticals by Countries
- 10.1.1 Middle East and Africa Biopharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa Biopharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Biopharmaceuticals by Product
- 10.3 Middle East and Africa Biopharmaceuticals by End User
11 Company Profiles
- 11.1 Roche
- 11.1.1 Roche Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Roche Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Roche Biopharmaceuticals Products Offered
- 11.1.5 Roche Recent Development
- 11.2 Amgen
- 11.2.1 Amgen Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Amgen Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Amgen Biopharmaceuticals Products Offered
- 11.2.5 Amgen Recent Development
- 11.3 AbbVie
- 11.3.1 AbbVie Company Details
- 11.3.2 Company Business Overview
- 11.3.3 AbbVie Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 AbbVie Biopharmaceuticals Products Offered
- 11.3.5 AbbVie Recent Development
- 11.4 Sanofi-Aventis
- 11.4.1 Sanofi-Aventis Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi-Aventis Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi-Aventis Biopharmaceuticals Products Offered
- 11.4.5 Sanofi-Aventis Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Johnson & Johnson Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Johnson & Johnson Biopharmaceuticals Products Offered
- 11.5.5 Johnson & Johnson Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Pfizer Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Pfizer Biopharmaceuticals Products Offered
- 11.6.5 Pfizer Recent Development
- 11.7 Novo Nordisk
- 11.7.1 Novo Nordisk Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Novo Nordisk Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Novo Nordisk Biopharmaceuticals Products Offered
- 11.7.5 Novo Nordisk Recent Development
- 11.8 Eli Lilly
- 11.8.1 Eli Lilly Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Eli Lilly Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Eli Lilly Biopharmaceuticals Products Offered
- 11.8.5 Eli Lilly Recent Development
- 11.9 Novartis
- 11.9.1 Novartis Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Novartis Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Novartis Biopharmaceuticals Products Offered
- 11.9.5 Novartis Recent Development
- 11.10 Merck
- 11.10.1 Merck Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Merck Biopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Merck Biopharmaceuticals Products Offered
- 11.10.5 Merck Recent Development
12 Future Forecast
- 12.1 Biopharmaceuticals Market Forecast by Regions
- 12.1.1 Global Biopharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global Biopharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.2 Biopharmaceuticals Market Forecast by Product
- 12.2.1 Global Biopharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global Biopharmaceuticals Revenue Forecast by Product 2019-2025
- 12.3 Biopharmaceuticals Market Forecast by End User
- 12.4 North America Biopharmaceuticals Forecast
- 12.5 Europe Biopharmaceuticals Forecast
- 12.6 Asia Pacific Biopharmaceuticals Forecast
- 12.7 Central & South America Biopharmaceuticals Forecast
- 12.8 Middle East and Africa Biopharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biopharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biopharmaceuticals . Industry analysis & Market Report on Biopharmaceuticals is a syndicated market report, published as Global Biopharmaceuticals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Biopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
